This lower level of induced leukocytosis may explain the smaller magnitude of cell count reductions with CRTH2 antagonism (fevipiprant) in our study, such as a 20% decrease in eosinophilia, compared to previous ex vivo studies with CRTH2 antagonists. The gene discussed is PTGDR2; the disease is Increased total leukocyte count.